1. Home
  2. LPL vs PGEN Comparison

LPL vs PGEN Comparison

Compare LPL & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LPL

LG Display Co Ltd AMERICAN DEPOSITORY SHARES

HOLD

Current Price

$2.60

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.20

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPL
PGEN
Founded
1985
1998
Country
South Korea
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
LPL
PGEN
Price
$2.60
$6.20
Analyst Decision
Hold
Buy
Analyst Count
2
4
Target Price
$4.31
★ $13.65
AVG Volume (30 Days)
2.0M
★ 4.6M
Earning Date
11-06-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.03
Revenue
N/A
★ $230,981,000.00
Revenue This Year
N/A
$2,365.68
Revenue Next Year
$2.70
$85.75
P/E Ratio
★ $25.64
$212.83
Revenue Growth
N/A
N/A
52 Week Low
$2.56
$3.04
52 Week High
$5.83
$8.98

Technical Indicators

Market Signals
Indicator
LPL
PGEN
Relative Strength Index (RSI) 31.27 34.75
Support Level $2.56 $6.08
Resistance Level $3.15 $7.30
Average True Range (ATR) 0.08 0.38
MACD -0.01 -0.18
Stochastic Oscillator 5.93 2.57

Price Performance

Historical Comparison
LPL
PGEN

About LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES

LG Display Co Ltd manufacture TFT-LCD and OLED technology-based display panels in a broad range of sizes and specifications mainly for use in IT products (comprising notebook computers, desktop monitors and tablet computers), televisions, mobile devices, including smartphones, as well as auto products, and it are one of the world's suppliers of large-sized OLED television panels. It also manufacture display panels for industrial and other applications, including entertainment systems and medical diagnostic equipment.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: